21
21P.F Aurora Cannabis Inc
- Market cap
- EUR 298M
- P/E
- -
- P/B
- 0.92x
- ROE
- -16.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.
Is 21P.F undervalued?
Graham numberThe Graham number of Aurora Cannabis Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aurora Cannabis Inc fundamental analysis
No fundamental analysis for Aurora Cannabis Inc yet.
Aurora Cannabis Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts,…
Full company profileAurora Cannabis Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aurora Cannabis Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 1.44M | 18.1M | 55.2M | 248M | 245M | 221M | 270M | 289M | 321M | 344M |
| Gross Profit | - | 2.20M | 16.1M | 43.5M | 160M | -21.6M | 21.2M | 132M | 181M | 137M | 150M |
| Operating Income | -4.37M | -4.59M | -9.64M | -80.1M | -297M | -247M | -219M | -31.1M | 10.4M | -46.7M | -71.7M |
| EBITDA | - | - | - | - | - | - | -1.55B | -11.1M | 46.4M | -40.5M | -61.2M |
| Net Income | -9.52M | -5.72M | -13.0M | 71.9M | -291M | -694M | -1.72B | -69.3M | 1.59M | -136M | -84.2M |
| EPS | - | - | - | - | - | -35 | -58 | -1.27 | 0.03 | -2.31 | -1.28 |
| Balance Sheet | |||||||||||
| Total Assets | 13.5M | 18.4M | 323M | 1.91B | 5.50B | 2.60B | 1.08B | 839M | 853M | 601M | 615M |
| Total Liabilities | 9.69M | 12.4M | 104M | 348M | 1.11B | 567M | 422M | 237M | 244M | 89.3M | 96.7M |
| Shareholders' Equity | 3.83M | 5.96M | 219M | 1.56B | 4.39B | 2.04B | 662M | 560M | 567M | 512M | 518M |
| Cash & Short-term Investments | 316K | 170K | 160M | 89.2M | 173M | 421M | 438M | 136M | 138M | 64.7M | 65.9M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -3.32M | -6.77M | -10.5M | -81.7M | -192M | -211M | -110M | -68.5M | 16.0M | -13.5M | -59.8M |
| Capital Expenditure | 7.83M | 1.88M | 25.7M | 137M | 414M | 53.1M | 32.2M | 16.8M | 18.9M | 22.5M | 25.4M |
| Free Cash Flow | - | - | - | - | - | -264M | -142M | -85.3M | -2.85M | -36.1M | -85.2M |
| Ratios | |||||||||||
| ROE | -248.3% | -96.0% | -5.9% | 4.6% | -6.6% | -34.0% | -259.5% | -12.4% | 0.3% | -26.6% | -16.2% |
| ROA | -70.4% | -31.1% | -4.0% | 3.8% | -5.3% | -26.6% | -158.4% | -8.3% | 0.2% | -22.6% | -13.7% |
| Net Profit Margin | - | -397.7% | -71.8% | 130.3% | -117.3% | -282.8% | -776.0% | -25.7% | 0.6% | -42.4% | -24.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Aurora Cannabis Inc dividends
Aurora Cannabis Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Feb 20, 2024.
Who owns Aurora Cannabis Inc
- Insiders 1.19%
- Institutions 14.37%
- Public & others 84.44%
- Shares outstanding 65.7M
- Free float 64.5M
Aurora Cannabis Inc company profile
- Company name
- Aurora Cannabis Inc
- Ticker
- 21P.F
- ISIN
- CA05156X8504
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 1,028
- Fiscal year end
- June
- Address
- 90B Street SW, Edmonton, AB, Canada, T6X 1V8
- Phone
- 855 279 4652
- Website
- auroramj.com
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Aurora Cannabis Inc management
9- Mr. Alex MillerExecutive VP of Operations & Supply Chain
- Ms. Nathalie ClarkExecutive VP, General Counsel & Corporate Secretary
- Ms. Lori SchickExecutive Vice President of Human Resources
- Kevin NilandSenior Director of Strategic Finance - Global FP&A and Investor Relations
- Ms. Michelle LeflerVice President of Communications & Public Relations
- Mr. Rick SavoneSenior Vice President of Global Government Relations
- Mr. David AirdExecutive Vice President of Information Technology
- Mr. Kerry MillerManaging Director for Australia & New Zealand
- Mr. Faris El RefaieExecutive Vice President of Global Commercial